Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.76 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.76 |
| ▸ | DRD2 | P14416 | 17/20 | 0.62 |
| ▸ | HTR1A | P08908 | 16/20 | 0.62 |
| ▸ | HTR2A | P28223 | 3/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.57 |
| ▸ | HTR6 | P50406 | 5/20 | 0.54 |
| ▸ | HTR7 | P34969 | 4/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14280720 | 0.87 | OPRM1 (1.00) | OPRM1OPRK1DRD2HTR1AHTR2A | |
| Hydrochloric Acid SCHEMBL11320856 | 0.79 | OPRM1 (0.73) | OPRM1OPRK1DRD2HTR1ASLC6A4 | |
| SCHEMBL11327571 | 0.79 | OPRM1 (0.73) | OPRM1OPRK1DRD2HTR1ASLC6A4 | |
| SCHEMBL7647977 | 0.78 | SLC6A4 (0.55) | OPRM1OPRK1DRD2HTR1ASLC6A4 | |
| Tepirindole SCHEMBL11307437 | 0.78 | SLC6A4 (0.72) | OPRM1OPRK1DRD2HTR1ASLC6A4 | |
| Tepirindole SCHEMBL635174 | 0.78 | SLC6A4 (0.72) | OPRM1OPRK1DRD2HTR1ASLC6A4 | |
| Tepirindole SCHEMBL29710897 | 0.78 | SLC6A4 (0.72) | OPRM1OPRK1DRD2HTR1ASLC6A4 | |
| SCHEMBL7536094 | 0.76 | OPRM1 (0.78) | OPRM1OPRK1DRD2HTR1AHTR2A | |
| SCHEMBL9527241 | 0.76 | OPRM1 (0.78) | OPRM1OPRK1DRD2HTR1AHTR2A | |
| SCHEMBL10366941 | 0.75 | OPRM1 (0.71) | OPRM1OPRK1DRD2HTR1ASLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6476028-B1 | Compounds and methods | SMITHKLINE BEECHAM CORPORATION | 2002-11-05 | — | — | US | claimed |
| EP-1037635-A4 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORP (US) | 2002-11-13 | — | — | EP | disclosed |
| US-6476028-B1 | Compounds and methods | SMITHKLINE BEECHAM CORPORATION | 2002-11-05 | — | — | US | disclosed |
| EP-1037635-A1 | COMPOUNDS AND METHODS | Smithkline Beecham (US) | 2000-09-27 | — | — | EP | disclosed |
| WO-1999017773-A1 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-04-15 | — | — | WO | disclosed |